TRIAL OF A PREDICTIVE ALGORITHM TO TRANSPLANT PRA PAT
TRIAL OF A PREDICTIVE ALGORITHM TO TRANSPLANT PRA PAT
批准号:
2072601
负责人:
John Secord Thompson
金额:
$15.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-08-01 至 1998-07-31
中文摘要
因先天感染而对人类白细胞抗原变得敏感的患者
移植和排斥、输血或怀孕经历
等待时间更长,才能找到没有反应的捐赠者。减少
与非致敏受者相比,移植物存活率也有所下降。
观察到的。伴随着这种延迟和结果的是增加的物理
和心理障碍。
我们开发了一种计算机化预测算法(KATS),它基于
在确定可接受与不可接受的私人和
公共人类白细胞抗原来源于每月的血清筛查结果。
本质上,该算法预测I类的选择性不匹配
高度致敏患者体内的抗原。回溯性研究有
验证了该算法的预测能力。在首字母中
回顾分析,每个参与中心利用他们的
自身患者小组检测6份相同的血清,共292个细胞
经检测,只有4个细胞的抗原与血清相同。
捐赠者。然而,利用预测,215个交叉匹配否定非
经鉴定为人类白细胞抗原I类。在一项多中心的回顾性研究中,
KATS计划预测最终交叉匹配率为95.3%,并成功
移植成功率为85.4%。在另一个多中心
回顾分析,预测移植成功的准确性
在高度致敏的患者中也被预测到。相同算法可以
用于预测难于随机选择的患者的相容供体
血小板输注。
我们现在建议改进对负交叉匹配的预测,并
通过该算法提高基于前瞻性预测的器官共享
从而缩短了等待时间,提高了上座率
在那些自愿强制分享肾脏的中心进行移植
根据Kats的预测和改进的结果。这些结果
将与同等敏化分层的对照组进行比较
在这方面,中心选择不强制分享肾脏的患者
基础。
英文摘要
Patients that become sensitized to HLA alloantigens by virtue of prior
transplantation and rejection, blood transfusions or pregnancy experience
longer waiting times before a none-reactive donor can be found. Decreased
graft survival as compared to unsensitized recipients has also been
observed. Accompanying this delay and outcome are the increased physical
and psychological morbidity.
We have developed a computerized predictive algorithm (KATS) that is based
upon the identification of Acceptable versus Unacceptable private and
public HLA antigens derived from the results of monthly serum screening.
In essence the algorithm predicts selective mismatches for class I
antigens in highly sensitized patients. Retrospective studies have
validated the predictive power of the algorithm. In an initial
retrospective analysis, in which each participating center utilized their
own patients panel to examine 6 identical serum, a total of 292 cells were
tested yet only 4 of the cells were 4 antigen identical with the serum
donor. Utilizing the predictions, however, 215 crossmatch negative non-
HLA class I were identified. In a multi-center retrospective study, the
KATS program predicted a negative final crossmatch 95.3% and a successful
transplant outcome 85.4% of the time. In another multi-center
retrospective analysis, the predictive accuracy of a successful transplant
in highly sensitized patients was also predicted. The same algorithm may
be used to predict compatible donors for patients refractory to random
platelet transfusion.
We now propose to improve the prediction for a negative crossmatch and
increase organ sharing bases on prospective predictions by the algorithm
thereby decreasing the waiting time, increasing the rate of
transplantation at those centers volunteering to mandatorily share kidneys
on the basis of the KATS predictions and improving outcome. These results
will be compared to a control group of equally sensitized stratified
patients whose centers choose not to mandatorily share kidneys on this
basis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies on the role of IL-23p19/IL-17 cascade in the pathogenesis of acute GVHD
-
批准号:8195616
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:John Secord Thompson
-
依托单位:
Studies on the role of IL-23p19/IL-17 cascade in the pathogenesis of acute GVHD
-
批准号:7797740
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:John Secord Thompson
-
依托单位:
Studies on the role of IL-23p19/IL-17 cascade in the pathogenesis of acute GVHD
-
批准号:7905753
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:John Secord Thompson
-
依托单位:
TRIAL OF A PREDICTIVE ALGORITHM TO TRANSPLANT PRA PAT
-
批准号:2072602
-
项目类别:
-
资助金额:$16.08万
-
财政年份:1995
-
负责人:John Secord Thompson
-
依托单位:
TRIAL OF A PREDICTIVE ALGORITHM TO TRANSPLANT PRA PAT
-
批准号:2457793
-
项目类别:
-
资助金额:$16.72万
-
财政年份:1995
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:2312653
-
项目类别:
-
资助金额:$50.09万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:2651058
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:2312649
-
项目类别:
-
资助金额:$39.25万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:6401615
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:2312650
-
项目类别:
-
资助金额:$16.05万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:2312655
-
项目类别:
-
资助金额:$20.28万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:2876044
-
项目类别:
-
资助金额:$17.8万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:6356153
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:6056784
-
项目类别:
-
资助金额:$13.36万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
THERAPY GROUPS TO STUDY T-CELL DEPLETION
-
批准号:2557650
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:John Secord Thompson
-
依托单位:
STUDENTS IN HEALTH PROFESSIONAL SCHOOLS
-
批准号:3545202
-
项目类别:
-
资助金额:$1.01万
-
财政年份:1983
-
负责人:John Secord Thompson
-
依托单位:
STUDENTS IN HEALTH PROFESSIONAL SCHOOLS
-
批准号:3545203
-
项目类别:
-
资助金额:$1.01万
-
财政年份:1983
-
负责人:John Secord Thompson
-
依托单位:
STUDENTS IN HEALTH PROFESSIONAL SCHOOLS
-
批准号:3545204
-
项目类别:
-
资助金额:$0.69万
-
财政年份:1983
-
负责人:John Secord Thompson
-
依托单位:
NON-HLA HUMAN GRANULOCYTE, MONOCYTE ENDOTHELIAL ANTIGENS
-
批准号:3127631
-
项目类别:
-
资助金额:$11.88万
-
财政年份:1980
-
负责人:John Secord Thompson
-
依托单位:
海外基金